Skip to main content

Jeff Lagasse

By Jeff Lagasse | 03:50 pm | January 20, 2023
In addition to exceeding its financial forecast, a national search will seek to replace its longtime CEO, who is retiring this year.
By Jeff Lagasse | 12:31 pm | January 20, 2023
The group says the program has devolved into a "cumbersome process" involving lengthy approvals and insurer negotiations.
By Jeff Lagasse | 11:55 am | January 20, 2023
The AG's office accused drugmakers of "unlawful, unfair, and deceptive business practices."
By Jeff Lagasse | 04:23 pm | January 19, 2023
Adverse drug events comprise 39% of the adverse events, making them the most common by far.
By Jeff Lagasse | 12:05 pm | January 19, 2023
Nearly all states indicated using at least one specified strategy to increase the behavioral health workforce.
By Jeff Lagasse | 07:08 pm | January 18, 2023
The action furthers a larger goal of improving the accuracy of the quality information that is publicly reported in the Five-Star Rating System.
By Jeff Lagasse | 12:15 pm | January 18, 2023
The company looks to transform smartphones into clinical devices that can facilitate earlier testing.
By Jeff Lagasse | 04:12 pm | January 17, 2023
The lawsuit alleges that manufacturers and pharmacy benefit managers have leveraged their market power to overcharge patients.
By Jeff Lagasse | 12:09 pm | January 17, 2023
With more than 1.8 million more Americans signing up for coverage, ACA marketplace enrollment in 2023 continues to outpace previous years.
By Jeff Lagasse | 04:34 pm | January 13, 2023
The decline was larger than the national average in the South, Midwest and West, and there was an increase in the Northeast.